Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature

References

• A snapshot of head and neck cancer. National Cancer Institute, 2011. Available at: http://www.cancer.gov/aboutnci/servingpeople/cancer-statistics/snapshots [Last accessed 30 June 2012]
   Google Scholar
• Forte T, Niu J, Lockwood GA, Bryant HE. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009. Cancer Causes Control 2012;23:1343-8
   PubMed Web of Science ®Google Scholar
• Chuang SC, Scelo G, Tonita JM, et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer 2008;123:2390-6
   PubMed Web of Science ®Google Scholar
• Tsou YA, Hua CH, Tseng HC, et al. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma. Acta Otolaryngol 2007;127:651-7
   PubMed Web of Science ®Google Scholar
• Priante AV, Castilho EC, Kowalski LP. Second primary tumors in patients with head and neck cancer. Curr Oncol Rep 2011;13:132-7
   PubMed Web of Science ®Google Scholar
• Day GL, Blot WJ, Shore RE, et al. Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst 1994;86:131-7
   PubMed Web of Science ®Google Scholar
• Lin K, Patel SG, Chu PY, et al. Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx. Head Neck 2005;27:1042-8
   PubMed Web of Science ®Google Scholar
• Lee KD, Lu CH, Chen PT, et al. The incidence and risk of developing a second primary esophageal cancer in patients with oral and pharyngeal carcinoma: a population-based study in Taiwan over a 25 year period. BMC Cancer 2009;9:373
   PubMed Web of Science ®Google Scholar
• Peck BW, Dahlstrom KR, Gan SJ, et al. Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers. Head Neck 2012: published online 19 June 2012, doi:10.1002/hed.23033
   Google Scholar
• Morris LG, Sikora AG, Hayes RB, et al. Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer. Cancer Causes Control 2011;22:671-9
   PubMed Web of Science ®Google Scholar
• Socié G, Scieux C, Gluckman E, et al. Squamous cell carcinomas after allogeneic bone marrow transplantation for aplastic anemia: further evidence of a multistep process. Transplantation 1998;66:667-70
   PubMed Web of Science ®Google Scholar
• Wang Z, Sturgis EM, Zhang F, et al. Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neck. Mol Cancer 2012;11:17
   PubMed Web of Science ®Google Scholar
• Hildebrandt MA, Lippman SM, Etzel CJ, et al. Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention. Clin Cancer Res 2012;18:3705-13
   PubMed Web of Science ®Google Scholar
• Azad AK, Bairati I, Samson E, et al. Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers. Cancer 2012;118:1554-65
   PubMed Web of Science ®Google Scholar
• Bosetti C, Scelo G, Chuang SC, et al. High constant incidence rates of second primary cancers of the head and neck: a pooled analysis of 13 cancer registries. Int J Cancer 2011;129:173-9
   PubMed Web of Science ®Google Scholar
• Rennemo E, Zätterström U, Boysen M. Impact of second primary tumors on survival in head and neck cancer: an analysis of 2,063 cases. Laryngoscope 2008;118:1350-6
   PubMed Web of Science ®Google Scholar
• Gao X, Fisher SG, Mohideen N, Emami B. Second primary cancers in patients with laryngeal cancer: a population-based study. Int J Radiat Oncol Biol Phys 2003;56:427-35
   PubMed Web of Science ®Google Scholar
• Warnakulasuriya KA, Robinson D, Evans H. Multiple primary tumours following head and neck cancer in southern England during 1961-98. J Oral Pathol Med 2003;32:443-9
   PubMed Web of Science ®Google Scholar
• Crosher R, McIlroy R. The incidence of other primary tumours in patients with oral cancer in Scotland. Br J Oral Maxillofac Surg 1998;36:58-62
   PubMed Web of Science ®Google Scholar
• Fijuth J, Mazeron JJ, Le Péchoux C, et al. Second head and neck cancers following radiation therapy of T1 and T2 cancers of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 1992;24:59-64
   PubMed Web of Science ®Google Scholar
• Kuss I, Hathaway B, Ferris R, et al. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res 2004;10:3755-62
   PubMed Web of Science ®Google Scholar
• Kuss I, Saito T, Johnson J, Whiteside T. Clinical significance of decreased ζ chain expression in peripheral blood lymphocytes of patients with head and neck cancer. Clin Cancer Res 1999;5:329-34
   PubMed Web of Science ®Google Scholar
• Haughey BH, Gates GA, Arfken CL, Harvey J. Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 1992;101:105-12
   PubMed Web of Science ®Google Scholar
• Spector JG, Sessions DG, Haughey BH, et al. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope 2001;111:1079-87
   PubMed Web of Science ®Google Scholar
• Licciardello JT, Spitz MR, Hong WK. Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. Int J Radiat Oncol Biol Phys 1989;17:467-76
   PubMed Web of Science ®Google Scholar
• Chen MC, Chen PT, Chan CH, et al. Second primary esophageal or lung cancer in patients with head and neck carcinoma in Taiwan: incidence and risk in relation to primary index tumor site. J Cancer Res Clin Oncol 2011;137:115-23
   PubMed Web of Science ®Google Scholar
• Chu PY, Chang SY, Huang JL, Tai SK. Different patterns of second primary malignancy in patients with squamous cell carcinoma of larynx and hypopharynx. Am J Otolaryngol 2010;31:168-74
   PubMed Web of Science ®Google Scholar
• Parker RG, Enstrom JE. Second primary cancers of the head and neck following treatment of initial primary head and neck cancers. Int J Radiat Oncol Biol Phys 1988;14:561-4
   PubMed Web of Science ®Google Scholar
• Shiga K, Tateda M, Katagiri K, et al. Distinct features of second primary malignancies in head and neck cancer patients in Japan. Tohoku J Exp Med 2011;225:5-12
   PubMed Web of Science ®Google Scholar
• Fang P, Jiao S, Zhang X, et al. Meta-analysis of ALDH2 variants and esophageal cancer in Asians. Asian Pac J Cancer Prev 2011;12:2623-7
   PubMed Web of Science ®Google Scholar
• Asakage T, Yokoyama A, Haneda T, et al. Genetic polymorphisms of alcohol and aldehyde dehydrogenases, and drinking, smoking and diet in Japanese men with oral and pharyngeal squamous cell carcinoma. Carcinogenesis 2007;28:865-74
   PubMed Web of Science ®Google Scholar
• Scélo G, Boffetta P, Corbex M, et al. Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries. Cancer Causes Control 2007;18:269-78
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Nakatogawa N, Ota Y, et al. Development of follicular lymphoma of the cervical lymph nodes in a postoperative patient with tongue cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2012;113:e35-9
   Web of Science ®Google Scholar
• Caraway NP, Wojcik EM, Saboorian HM, Katz RL. Concomitant lymphoma and metastatic carcinoma in a lymph node: diagnosis by fine-needle aspiration biopsy in two cases. Diagn Cytopathol 1997;17:287-91
   PubMed Web of Science ®Google Scholar
• Millwaters M, Khan N, Halfpenny W. Simultaneous lymphoma and squamous cell carcinoma presenting as a neck lump. Br J Oral Maxillofac Surg 2008;46:144-5
   PubMed Web of Science ®Google Scholar
• Holland JM, Arsanjani A, Liem BJ, et al. Second malignancies in early stage laryngeal carcinoma patients treated with radiotherapy. J Laryngol Otol 2002;116:190-3
   PubMed Web of Science ®Google Scholar
• Milano MT, Peterson CR 3rd, Zhang H, et al. Second primary lung cancer after head and neck squamous cell cancer: population-based study of risk factors. Head Neck 2012: published online 9 February 2012, doi:10.1002/hed.22006
   Google Scholar
• Jayaprakash V, Cheng C, Reid M, et al. Previous head and neck cancers portend poor prognoses in lung cancer patients. Ann Thorac Surg 2011;92:1056-60
   PubMed Web of Science ®Google Scholar
• Dequanter D, Shahla M, Lardinois I, et al. Second primary lung malignancy in head and neck cancer patients. Eur Ann Otorhinolaryngol Head Neck Dis 2011;128:11-13
   PubMed Web of Science ®Google Scholar
• Lee P, de Bree R, Brokx HA, et al. Primary lung cancer after treatment of head and neck cancer without lymph node metastasis: is there a role for autofluorescence bronchoscopy? Lung Cancer 2008;62:309-15
   PubMed Web of Science ®Google Scholar
• Hsu YB, Chang SY, Lan MC, et al. Second primary malignancies in squamous cell carcinomas of the tongue and larynx: an analysis of incidence, pattern, and outcome. J Chin Med Assoc 2008;71:86-91
   PubMed Web of Science ®Google Scholar
• Natsugoe S, Uchino Y, Kijima F, et al. Synchronous and metachronous carcinomas of the esophagus and head and neck. Dis Esophagus 1997;10:134-8
   PubMedGoogle Scholar
• Di Martino E, Sellhaus B, Hausmann R, et al. Survival in second primary malignancies of patients with head and neck cancer. J Laryngol Otol 2002;116:831-8
   PubMed Web of Science ®Google Scholar
• Graff P, Schipman B, Desandes E, et al. Management of patients with head and neck tumours presenting at diagnosis with a synchronous second cancer at another anatomic site. Clin Oncol (R Coll Radiol) 2011;23:174-81
   PubMed Web of Science ®Google Scholar
• Manikantan K, Dwivedi RC, Sayed SI, et al. Current concepts of surveillance and its significance in head and neck cancer. Ann R Coll Surg Engl 2011;93:576-82
   PubMed Web of Science ®Google Scholar
• Ritoe SC, Krabbe PF, Jansen MM, et al. Screening for second primary lung cancer after treatment of laryngeal cancer. Laryngoscope 2002;112:2002-8
   PubMed Web of Science ®Google Scholar
• Stoeckli SJ, Zimmermann R, Schmid S. Role of routine panendoscopy in cancer of the upper aerodigestive tract. Otolaryngol Head Neck Surg 2001;124:208-12
   PubMed Web of Science ®Google Scholar
• Shaha AR, Hoover EL, Mitrani M, et al. Synchronicity, multicentricity, and metachronicity of head and neck cancer. Head Neck Surg 1988;10:225-8
   PubMedGoogle Scholar
• Rodriguez-Bruno K, Ali MJ, Wang SJ. Role of panendoscopy to identify synchronous second primary malignancies in patients with oral cavity and oropharyngeal squamous cell carcinoma. Head Neck 2011;33:949-53
   PubMed Web of Science ®Google Scholar
• Paniello RC, Virgo KS, Johnson MH, et al. Practice patterns and clinical guidelines for posttreatment follow-up of head and neck cancers: a comparison of 2 professional societies. Arch Otolaryngol Head Neck Surg 1999;125:309-13
   PubMed Web of Science ®Google Scholar
• Joshi A, Calman F, O’Connell M, et al. Current trends in the follow-up of head and neck cancer patients in the UK. Clin Oncol (R Coll Radiol) 2010;22:114-18
   PubMed Web of Science ®Google Scholar
• Hong W, Lippman S, Itri L, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990;323:795-801
   PubMed Web of Science ®Google Scholar
• Jyothirmayi R, Ramadas K, Varghese C, et al. Efficacy of vitamin A in the prevention of loco-regional recurrence and second primaries in head and neck cancer. Eur J Cancer B Oral Oncol 1996;32B:373-6
   PubMed Web of Science ®Google Scholar
• Koch WM. Early Diagnosis and Treatment of Cancer Series: Head and Neck Cancer. Philadelphia: Saunders, 2010
   Google Scholar
• Kim J, Amin A, Shin D. Chemoprevention of head and neck cancer with green tea polyphenols. Cancer Prev Res 2010;3:900-9
   PubMed Web of Science ®Google Scholar
• Masuda M, Wakasaki T, Toh S, et al. Chemoprevention of head and neck cancer by green tea extract: EGCG- the role of EGFR signaling and “lipid raft.” J Oncol 2011: published online 2 January 2011, doi: 10.1155/2011/540148
   Google Scholar
• Khariwala S, Carmella SG, Stepanov I, et al. Elevated levels of 1-hydroxypyrene and N’-nitrosonornicotine in smokers with head and neck cancer: a matched control study. Head Neck 2012: published online 17 July 2012, doi: 10.1002/hed.23085
   Google Scholar
• Psyrri A, Sasaki C, Vassilakopoulou M, et al. Future directions in research, treatment and prevention of HPV-related squamous cell carcinoma of the head and neck. Head Neck Pathol 2012;6(Suppl 1):121-8
   PubMedGoogle Scholar
• Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Nat Cancer Inst 2000;92:709-20
   PubMed Web of Science ®Google Scholar
• Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol Off J Am Soc Clin Oncol 2006;24:736-47
   PubMed Web of Science ®Google Scholar
• Chen AM, Phillips TL, Lee NY. Practical considerations in the re-irradiation of recurrent and second primary head-and-neck cancer: who, why, how, and how much? Int J Radiat Oncol Biol Phys 2011;81:1211-19
   PubMed Web of Science ®Google Scholar